Cleveland Clinic Abu Dhabi has become the first hospital in the Middle East and North Africa (MENA) region to deploy the Artisse Intrasaccular Flow Modulator, a cutting-edge device designed to treat wide-necked brain aneurysms. This innovative technology offers a minimally invasive alternative to traditional brain surgery, enhancing patient safety and treatment effectiveness. As a designated Centre of Excellence for stroke by the Department of Health – Abu Dhabi, the hospital reinforces its leadership in advanced neurological care.
A brain aneurysm, also known as a cerebral aneurysm, is a bulge in a weakened area of an artery in or around the brain. If the aneurysm ruptures, it can lead to a subarachnoid hemorrhage, a type of stroke caused by bleeding in the brain. Traditional treatment methods often involve invasive surgery, which carries higher risks and longer recovery times.
The Artisse device is a mesh-like implant designed to be placed within the aneurysm sac. It works by diverting blood flow away from the aneurysm, allowing the vessel to heal and reducing the risk of rupture. This procedure is performed using a catheter inserted through a blood vessel, typically in the groin or arm, to reach the aneurysm in the brain. Advanced 3D imaging and angiography are utilized to precisely assess and position the device.
The first patient treated with the Artisse device at Cleveland Clinic Abu Dhabi showed successful aneurysm closure within three months, demonstrating the promising potential of this innovative treatment.
Cleveland Clinic Abu Dhabi’s adoption of the Artisse Intrasaccular Flow Modulator underscores its commitment to providing world-class care and advancing medical technology in the region. By introducing this first-of-its-kind treatment in the MENA region, the hospital continues to lead in the field of neurological care.
For more information or to schedule a consultation, visit Cleveland Clinic Abu Dhabi’s official website.
